Find Federal Grants
Proteome Characterization Centers (PCCs) for Clinical Proteomic Tumor Analysis Consortium (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-CA-21-023
Proteogenomic Translational Research Centers (PTRCs) for Clinical Proteomic Tumor Analysis Consortium (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-CA-21-025
Proteogenomic Data Analysis Centers (PGDACs) for Clinical Proteomic Tumor Analysis Consortium (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-CA-21-024
Rural Utilities Service · RUS-21-01-DLT
Centers for Disease Control - OSTLTS · CDC-RFA-OT21-2102
National Institutes of Health · RFA-AI-21-019
Intramural - Extramural Collaboration for Drug Screening with Biofabricated 3-D Disease Tissue Models (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health · RFA-TR-21-015
Limited Competition Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-22-002
Short-Term Mentored Research Career Enhancement Award to Promote Diversity (K18 No Independent Clinical Trials)
National Institutes of Health · PA-21-214
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
National Institutes of Health · PAR-21-197
Improving Health of Americans with Intellectual and Developmental Disabilities Through Evidence-Based Health Promotion Programs
Centers for Disease Control - NCBDDD · CDC-RFA-DD21-2102
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
National Institutes of Health · RFA-RM-21-012
Improving Health of Americans with Mobility Limitations Through Evidence-Based Health Promotion Programs
Centers for Disease Control - NCBDDD · CDC-RFA-DD21-2104
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
National Institutes of Health · PAR-21-210
Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required)
National Institutes of Health · PAR-21-211
Mentoring Networks to Enhance Diversity in NIDCD's Extramural Research Workforce (R25 Clinical Trial Not Allowed)
National Institutes of Health · PAR-21-185
Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed)
National Institutes of Health · PAR-21-196
Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Technology and Analytic Cores (TACs) and Research Management Unit (RMU) (UC2 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AR-21-016
Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases, and Sjgrens Syndrome (UC2 Clinical Trial Optional)
National Institutes of Health · RFA-AR-21-015
Technologies to Advance Precision Medicine for Reproductive Health and Infertility (R43, R44 Clinical Trial Optional)
National Institutes of Health · RFA-HD-22-010